Cargando…

Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up

This study aimed to compare and assess clinical outcomes of spinal metastasis with epidural spinal cord compression (MESCC) in patients aged 65–79 years and ≥ 80 years with an acute onset of neurological illness who underwent laminectomy. A second goal was to determine morbidity rates and potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenga, Pavlina, Dao Trong, Philip, Papakonstantinou, Vassilios, Kiening, Karl, Unterberg, Andreas W., Ishak, Basem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663192/
https://www.ncbi.nlm.nih.gov/pubmed/37987881
http://dx.doi.org/10.1007/s10143-023-02217-8
_version_ 1785148629090041856
author Lenga, Pavlina
Dao Trong, Philip
Papakonstantinou, Vassilios
Kiening, Karl
Unterberg, Andreas W.
Ishak, Basem
author_facet Lenga, Pavlina
Dao Trong, Philip
Papakonstantinou, Vassilios
Kiening, Karl
Unterberg, Andreas W.
Ishak, Basem
author_sort Lenga, Pavlina
collection PubMed
description This study aimed to compare and assess clinical outcomes of spinal metastasis with epidural spinal cord compression (MESCC) in patients aged 65–79 years and ≥ 80 years with an acute onset of neurological illness who underwent laminectomy. A second goal was to determine morbidity rates and potential risk factors for mortality. This retrospective review of electronic medical records at a single institution was conducted between September 2005 and December 2020. Data on patient demographics, surgical characteristics, complications, hospital clinical course, and 90-day mortality were also collected. Comorbidities were assessed using the age-adjusted Charlson comorbidity index (CCI). A total of 99 patients with an overall mean age of 76.2 ± 3.4 years diagnosed with MESCC within a 16-year period, of which 65 patients aged 65–79 years and 34 patients aged 80 years and older were enrolled in the study. Patients aged 80 and over had higher age-adjusted CCI (9.2 ± 2.1) compared to those aged 65–79 (5.1 ± 1.6; p < 0.001). Prostate cancer was the primary cause of spinal metastasis. Significant neurological and functional decline was more pronounced in the older group, evidenced by Karnofsky Performance Index (KPI) scores (80+ years: 47.8% ± 19.5; 65–79 years: 69.0% ± 23.9; p < 0.001). Despite requiring shorter decompression duration (148.8 ± 62.5 min vs. 199.4 ± 78.9 min; p = 0.004), the older group had more spinal levels needing decompression. Median survival time was 14.1 ± 4.3 months. Mortality risk factors included deteriorating functional status and comorbidities, but not motor weakness, surgical duration, extension of surgery, hospital or ICU stay, or complications. Overcoming age barriers in elderly surgical treatment in MSCC patients can reduce procedural delays and has the potential to significantly improve patient functionality. It emphasizes that age should not be a deterrent for spine surgery when medically necessary, although older MESCC patients may have reduced survival.
format Online
Article
Text
id pubmed-10663192
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106631922023-11-21 Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up Lenga, Pavlina Dao Trong, Philip Papakonstantinou, Vassilios Kiening, Karl Unterberg, Andreas W. Ishak, Basem Neurosurg Rev Research This study aimed to compare and assess clinical outcomes of spinal metastasis with epidural spinal cord compression (MESCC) in patients aged 65–79 years and ≥ 80 years with an acute onset of neurological illness who underwent laminectomy. A second goal was to determine morbidity rates and potential risk factors for mortality. This retrospective review of electronic medical records at a single institution was conducted between September 2005 and December 2020. Data on patient demographics, surgical characteristics, complications, hospital clinical course, and 90-day mortality were also collected. Comorbidities were assessed using the age-adjusted Charlson comorbidity index (CCI). A total of 99 patients with an overall mean age of 76.2 ± 3.4 years diagnosed with MESCC within a 16-year period, of which 65 patients aged 65–79 years and 34 patients aged 80 years and older were enrolled in the study. Patients aged 80 and over had higher age-adjusted CCI (9.2 ± 2.1) compared to those aged 65–79 (5.1 ± 1.6; p < 0.001). Prostate cancer was the primary cause of spinal metastasis. Significant neurological and functional decline was more pronounced in the older group, evidenced by Karnofsky Performance Index (KPI) scores (80+ years: 47.8% ± 19.5; 65–79 years: 69.0% ± 23.9; p < 0.001). Despite requiring shorter decompression duration (148.8 ± 62.5 min vs. 199.4 ± 78.9 min; p = 0.004), the older group had more spinal levels needing decompression. Median survival time was 14.1 ± 4.3 months. Mortality risk factors included deteriorating functional status and comorbidities, but not motor weakness, surgical duration, extension of surgery, hospital or ICU stay, or complications. Overcoming age barriers in elderly surgical treatment in MSCC patients can reduce procedural delays and has the potential to significantly improve patient functionality. It emphasizes that age should not be a deterrent for spine surgery when medically necessary, although older MESCC patients may have reduced survival. Springer Berlin Heidelberg 2023-11-21 2023 /pmc/articles/PMC10663192/ /pubmed/37987881 http://dx.doi.org/10.1007/s10143-023-02217-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Lenga, Pavlina
Dao Trong, Philip
Papakonstantinou, Vassilios
Kiening, Karl
Unterberg, Andreas W.
Ishak, Basem
Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title_full Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title_fullStr Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title_full_unstemmed Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title_short Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
title_sort reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-up
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663192/
https://www.ncbi.nlm.nih.gov/pubmed/37987881
http://dx.doi.org/10.1007/s10143-023-02217-8
work_keys_str_mv AT lengapavlina reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup
AT daotrongphilip reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup
AT papakonstantinouvassilios reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup
AT kieningkarl reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup
AT unterbergandreasw reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup
AT ishakbasem reevaluatingagerestrictionsofspinalmetastasissurgeryinelderlygroupswithover2yearfollowup